JP2009519339A5 - - Google Patents

Download PDF

Info

Publication number
JP2009519339A5
JP2009519339A5 JP2008545718A JP2008545718A JP2009519339A5 JP 2009519339 A5 JP2009519339 A5 JP 2009519339A5 JP 2008545718 A JP2008545718 A JP 2008545718A JP 2008545718 A JP2008545718 A JP 2008545718A JP 2009519339 A5 JP2009519339 A5 JP 2009519339A5
Authority
JP
Japan
Prior art keywords
mir
mirna
pharmaceutical composition
gene
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008545718A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009519339A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/047255 external-priority patent/WO2007070483A2/en
Publication of JP2009519339A publication Critical patent/JP2009519339A/ja
Publication of JP2009519339A5 publication Critical patent/JP2009519339A5/ja
Pending legal-status Critical Current

Links

JP2008545718A 2005-12-12 2006-12-12 筋細胞増殖及び分化を調節するマイクロrna Pending JP2009519339A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74954405P 2005-12-12 2005-12-12
PCT/US2006/047255 WO2007070483A2 (en) 2005-12-12 2006-12-12 Micrornas that regulate muscle cell proliferation and differentiation

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2013027633A Division JP5796027B2 (ja) 2005-12-12 2013-02-15 筋細胞増殖及び分化を調節するマイクロrna
JP2013253829A Division JP5740460B2 (ja) 2005-12-12 2013-12-09 筋細胞増殖及び分化を調節するマイクロrna

Publications (2)

Publication Number Publication Date
JP2009519339A JP2009519339A (ja) 2009-05-14
JP2009519339A5 true JP2009519339A5 (enExample) 2010-01-14

Family

ID=38163464

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008545718A Pending JP2009519339A (ja) 2005-12-12 2006-12-12 筋細胞増殖及び分化を調節するマイクロrna
JP2013027633A Expired - Fee Related JP5796027B2 (ja) 2005-12-12 2013-02-15 筋細胞増殖及び分化を調節するマイクロrna
JP2013253829A Expired - Fee Related JP5740460B2 (ja) 2005-12-12 2013-12-09 筋細胞増殖及び分化を調節するマイクロrna

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013027633A Expired - Fee Related JP5796027B2 (ja) 2005-12-12 2013-02-15 筋細胞増殖及び分化を調節するマイクロrna
JP2013253829A Expired - Fee Related JP5740460B2 (ja) 2005-12-12 2013-12-09 筋細胞増殖及び分化を調節するマイクロrna

Country Status (14)

Country Link
US (3) US8431542B2 (enExample)
EP (3) EP1969125B1 (enExample)
JP (3) JP2009519339A (enExample)
KR (2) KR20140130562A (enExample)
CN (2) CN104027818A (enExample)
AU (1) AU2006326517B2 (enExample)
BR (1) BRPI0619755A2 (enExample)
CA (2) CA2903764A1 (enExample)
DK (1) DK1969125T3 (enExample)
ES (1) ES2387250T3 (enExample)
NZ (3) NZ569738A (enExample)
PL (1) PL1969125T3 (enExample)
PT (1) PT1969125E (enExample)
WO (1) WO2007070483A2 (enExample)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8592384B2 (en) 2005-04-04 2013-11-26 The Board Of Regents Of The University Of Texas System Micro-RNA's that regulate muscle cells
PL1969125T3 (pl) 2005-12-12 2012-11-30 Univ North Carolina Chapel Hill Mikrorna, które regulują proliferację i różnicowanie komórek mięśniowych
ES2397439T3 (es) 2006-08-01 2013-03-07 Board Of Regents Of The University Of Texas System Identificación de un microARN que activa la expresión de la cadena pesada beta de la miosina
GB2440782A (en) 2006-08-04 2008-02-13 Cesare Peschle Uses and compositions comprising miRNAs
EP4082551A1 (en) 2006-08-08 2022-11-02 Rheinische Friedrich-Wilhelms-Universität Bonn Structure and use of 5' phosphate oligonucleotides
US20110111496A1 (en) * 2007-06-29 2011-05-12 Chiang Li BACTERIA-MEDIATED GENE MODULATION VIA microRNA MACHINERY
US8481507B2 (en) * 2007-07-31 2013-07-09 The Board Of Regents, The University Of Texas System Micro-RNAs that control myosin expression and myofiber identity
US8440636B2 (en) 2007-07-31 2013-05-14 The Board Of Regents, The University Of Texas System Micro-RNA family that modulates fibrosis and uses thereof
WO2009105759A2 (en) * 2008-02-21 2009-08-27 The Board Of Regents Of The University Of Texas System Micro-rnas that modulate smooth muscle proliferation and differentiation and uses thereof
EP2265291B1 (en) * 2008-03-17 2016-10-19 The Board of Regents of The University of Texas System Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration
EP2297323A1 (en) 2008-05-21 2011-03-23 Hartmann, Gunther 5' triphosphate oligonucleotide with blunt end and uses thereof
AU2009257663B2 (en) * 2008-06-09 2014-06-26 New York Medical College Compositions comprising cardiac stem cells overexpressing specific microRNA and methods of their use in repairing damaged myocardium
GB0811715D0 (en) * 2008-06-26 2008-07-30 Angeletti P Ist Richerche Bio Therapeutic agents
MX2011008190A (es) 2009-02-04 2011-10-06 Univ Texas Direccionamiento dual de mir-208 y mir-499 en el tratamiento de trastornos cardiacos.
WO2010129672A1 (en) 2009-05-05 2010-11-11 Miragen Therapeutics Lipophilic polynucleotide conjugates
US20120059159A1 (en) * 2009-05-25 2012-03-08 Carola Ponzetto Differentiation therapy for sarcomas
JP5748736B2 (ja) * 2010-02-26 2015-07-15 Lsipファンド運営合同会社 筋原性疾患検出用マーカー及びそれを用いた検出方法
CN103108953B (zh) * 2010-04-08 2015-04-08 京都府公立大学法人 使用来自体液的样本检测横纹肌肉瘤的方法
CA2804791C (en) 2010-07-08 2019-07-30 Duke University Direct reprogramming of cells to cardiac myocyte fate
KR101235256B1 (ko) * 2010-09-13 2013-02-21 서울대학교산학협력단 miRNA를 타겟으로 한 신경퇴행성 질환 치료
CA2817002C (en) * 2010-11-05 2019-01-15 Miragen Therapeutics Base modified oligonucleotides
US20130302293A1 (en) * 2010-11-11 2013-11-14 Keith A. Webster Compositions, cells, kits and methods for autologous stem cell therapy
CN103380215A (zh) 2010-12-15 2013-10-30 米拉根医疗公司 包含锁定核苷酸的微rna抑制剂
EP2508530A1 (en) 2011-03-28 2012-10-10 Rheinische Friedrich-Wilhelms-Universität Bonn Purification of triphosphorylated oligonucleotides using capture tags
AU2012252165A1 (en) 2011-05-09 2013-03-21 Cambridge Enterprise Limited Methods of modulating micrornas in the treatment of pulmonary arterial hypertension
CN103764173A (zh) * 2011-07-01 2014-04-30 得克萨斯系统大学董事会 用于治疗骨骼肌病的组合物和方法
EP2731422B1 (en) * 2011-07-12 2017-08-09 Mart Saarma miRNA antagonists for use in treating neurodegenerative disorders by increasing expression of GDNF
WO2013037065A1 (en) * 2011-09-13 2013-03-21 Ottawa Hospital Research Institute Microrna inhibitors
JP6177243B2 (ja) 2011-10-06 2017-08-09 ミラゲン セラピューティクス, インコーポレイテッド マイクロrnaの調節による全身エネルギーホメオスタシスの制御
DK3354734T3 (da) 2012-06-21 2020-06-29 Miragen Therapeutics Inc Oligonukleotid-baserede hæmmere omfattende låst nukleinsyremønster
EP2712870A1 (en) 2012-09-27 2014-04-02 Rheinische Friedrich-Wilhelms-Universität Bonn Novel RIG-I ligands and methods for producing them
WO2014151835A1 (en) 2013-03-15 2014-09-25 Miragen Therapeutics, Inc Locked nucleic acid inhibitor of mir-145 and uses thereof
AU2014233115B2 (en) 2013-03-15 2019-08-01 MiRagen Therapeutics, Inc. Bridged bicyclic nucleosides
US9624471B2 (en) 2013-06-12 2017-04-18 University Of Washington Through Its Center For Commercialization Methods for maturing cardiomyocytes and uses thereof
CN103710387B (zh) * 2013-12-25 2015-10-14 天津农学院 一种促进牛骨骼肌卫星细胞体外增殖的方法
JP6566536B2 (ja) * 2014-06-16 2019-08-28 国立大学法人山口大学 フォワードプライマー
CN104498497A (zh) * 2014-12-10 2015-04-08 山东农业大学 一种与奶山羊乳腺上皮细胞凋亡相关的miRNA及其在奶山羊育种中的应用
US10620109B2 (en) 2015-01-14 2020-04-14 Kyoto University Method for selecting skeletal muscle progenitor cell
US9885042B2 (en) 2015-01-20 2018-02-06 MiRagen Therapeutics, Inc. miR-92 inhibitors and uses thereof
CN104877960B (zh) * 2015-06-01 2017-09-19 东北农业大学 miR‑2400显著促进牛骨骼肌卫星细胞增殖的生物功能
WO2017156015A2 (en) 2016-03-07 2017-09-14 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Micrornas and methods of their use
CN105713972A (zh) * 2016-03-16 2016-06-29 上海中医药大学 miRNA在制备药物性心脏病生物标志物中的用途
CN106399473B (zh) * 2016-08-23 2019-12-06 南京大学 检测和评价力量训练效果的miRNA标志物或其组合及其应用
WO2018070510A1 (ja) * 2016-10-13 2018-04-19 国立研究開発法人国立精神・神経医療研究センター 筋分化誘導剤
WO2018080658A1 (en) * 2016-10-27 2018-05-03 Aalborg University Therapeutic targeting of a microrna to treat duchenne muscular dystrophy
CN108324946B (zh) * 2017-01-20 2022-02-18 上海市东方医院 miRNA708、和/或301簇的微小RNA在改善心脏功能方面的应用
CN107096030A (zh) * 2017-03-20 2017-08-29 天津农学院 一种利用miR‑143抑制剂延缓小鼠失神经后肌肉萎缩的方法
US11365412B2 (en) 2017-04-05 2022-06-21 University Of Cincinnati Promotion of cardiomyocyte proliferation and regenerative treatment of the heart by inhibition of microRNA-128
WO2019035690A1 (ko) * 2017-08-18 2019-02-21 서울대학교병원 근육 질환 및 신경근육 질환 예방, 치료 또는 진단을 위한 miR-18b의 용도
KR102177130B1 (ko) 2017-08-18 2020-11-10 (주)큐라미스 근육 질환 및 신경근육 질환 예방, 치료 또는 진단을 위한 miR-18b의 용도
JP7279953B2 (ja) * 2017-12-08 2023-05-23 ユニバーシティ オブ ワシントン カルジオリピンのリモデリング及び心筋細胞の成熟を検出、及び促進する方法及び組成物、並びにミトコンドリア機能障害治療の関連する方法
WO2019178410A1 (en) * 2018-03-14 2019-09-19 Beth Israel Deaconess Medical Center Micro-rna and obesity
CN108690846A (zh) * 2018-04-17 2018-10-23 上海大学 抑制MiR-29b基因表达的应用
CN108823209B (zh) * 2018-07-18 2021-04-09 华中农业大学 骨骼肌特异性启动子及应用
KR20210102870A (ko) 2018-08-30 2021-08-20 테나야 테라퓨틱스, 인코포레이티드 미오카르딘 및 ascl1을 사용한 심장 세포 재프로그래밍
CN111041052B (zh) * 2019-12-30 2021-05-28 嘉兴学院 mir-206在抑制猪脂肪细胞内的甘油三酯生成以及瘦肉猪育种中的应用
CN115552022A (zh) * 2020-03-02 2022-12-30 特纳亚治疗股份有限公司 由心肌细胞表达的微rna控制的基因载体
BR112022019889A2 (pt) 2020-04-02 2023-03-07 Mirecule Inc Inibição direcionada com o uso de oligonucleotídeos modificados geneticamente
CN112266912A (zh) * 2020-10-22 2021-01-26 上海大学 靶向miR-29b的gRNA、AAV8-CRISPR/Cas9系统及其应用
WO2023034966A1 (en) * 2021-09-03 2023-03-09 The University Of North Carolina At Chapel Hill Compositions and methods of using the same for treating disorders associated with thymosin βeta 4
CN114480672B (zh) * 2022-02-22 2023-08-15 青岛农业大学 一种通过miR-145筛选高产肉率碱地黑牛的方法
CN114748497B (zh) * 2022-04-27 2024-10-18 广州市妇女儿童医疗中心 一种调控子宫肌收缩的miRNA分子miR-206及其应用
CN115181722B (zh) * 2022-08-30 2024-06-11 江苏农牧科技职业学院 一种鹅骨骼肌卫星细胞的体外分离和培养方法
CN117511884B (zh) * 2023-12-06 2024-06-11 中国农业科学院兰州畜牧与兽药研究所 Rtl1在抑制牦牛成肌细胞分化中的应用
KR20250173053A (ko) * 2024-05-31 2025-12-10 충남대학교산학협력단 전구체 miRNA를 포함하는 근육 감소 또는 근육 위축 예방, 개선 또는 치료용 조성물
KR20250173054A (ko) * 2024-05-31 2025-12-10 충남대학교산학협력단 전구체 miRNA를 포함하는 근육 감소 또는 근육 위축 진단용 바이오마커 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803782B2 (en) * 2003-05-28 2010-09-28 Roche Madison Inc. Intravenous delivery of polynucleotides to cells in mammalian limb
US20050124566A1 (en) * 2001-05-18 2005-06-09 Sirna Therapeutics, Inc. RNA interference mediated inhibition of myostatin gene expression using short interfering nucleic acid (siNA)
JP4371812B2 (ja) * 2001-09-28 2009-11-25 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ マイクロrna分子
US7781415B2 (en) * 2003-02-07 2010-08-24 Roche Madison Inc. Process for delivering sirna to cardiac muscle tissue
US20060247193A1 (en) 2003-02-10 2006-11-02 National Institute Of Advanced Industrial Science And Technology Regulation of gene expression by dna interference
SE521643C2 (sv) * 2003-02-26 2003-11-18 Scania Cv Publ Kraftöverföring med från en huvudväxel skild rangeväxel
ES2534304T3 (es) * 2004-11-12 2015-04-21 Asuragen, Inc. Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
US8592384B2 (en) * 2005-04-04 2013-11-26 The Board Of Regents Of The University Of Texas System Micro-RNA's that regulate muscle cells
WO2006113540A2 (en) 2005-04-14 2006-10-26 Duke University Use of ntrosylated hemoglobin
PL1969125T3 (pl) 2005-12-12 2012-11-30 Univ North Carolina Chapel Hill Mikrorna, które regulują proliferację i różnicowanie komórek mięśniowych

Similar Documents

Publication Publication Date Title
JP2009519339A5 (enExample)
Liu et al. The pivotal role of chemical modifications in mRNA therapeutics
US8691965B2 (en) Oligonucleotides for modulating target RNA activity
JP7093728B2 (ja) 化学的に修飾されたガイドrnaを使用する高特異性ゲノム編集
JP6700227B2 (ja) タンパク質又はペプチドの発現を改善するための人工核酸分子
CN112022870B (zh) 用于治疗缺血性损伤的化合物
JP7068821B2 (ja) 化学修飾を有するガイドrna
JP2012519484A5 (enExample)
JP2014527401A5 (enExample)
CA3081346A1 (en) Novel crispr-associated transposon systems and components
Mizuno et al. Regulation of gene expression by a small RNA transcript (micRNA) in Escherichia coli K-12
JP2002272489A5 (enExample)
JP2013510561A5 (enExample)
JP2019527563A5 (enExample)
EP2838912A1 (en) Peptides for the binding of nucleotide targets
Philippen et al. Antisense MicroRNA therapeutics in cardiovascular disease: quo vadis?
CN104540527A (zh) Mir-15微小rna家族的抑制剂
JP2013507934A5 (enExample)
CN110431230A (zh) 慢病毒和非整合型慢病毒作为病毒载体实施crispr治疗
WO2013013165A2 (en) Use of lna compounds for therapeutic inhibition of mir-21 in systemic lupus erythematosus
CN101402945A (zh) 表达抗传染性法氏囊病病毒微小rna重组禽腺联病毒的制备方法
CN106103714B (zh) 体内感染微生物、寄生微生物、共生微生物的非编码性rna及其鉴定和应用
KR102679172B1 (ko) 질환 세포-특이적인 miRNA에 의해 세포 생리 활성 조절 물질의 활성을 조절하는 복합체 및 이를 CRISPR/Cas 시스템에 적용한 질환 특이적 유전자 조작용 복합체
Pérez et al. MicroRNA interference
EP4223881A1 (en) Nucleic acid delivery method and system